Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency,...
Pfizer has been ranked first in its COVID-19 response, patient centricity, patient safety and bringing innovative, high-...
The Health Sciences Authority (HSA) in Singapore has extended the authorisation of Moderna’s Spikevax COVI...
Australia-based Antisense Therapeutics has announced the outcomes from its collaboration to study the neurological aspec...
The city-state Singapore is currently facing another wave of COVID-19 infections driven by the Omicron variants, BA.5 an...
Novavax has announced that its COVID-19 caccine, Adjuvanted (NVX-CoV2373) has received expanded emergency use autho...
US-based Novavax has announced that New Zealand (NZ)'s Medsafe has granted expanded provisional approval for Nuvaxovid (...
China-headquartered global biopharmaceutical company Frontier Biotechnologies announced positive results from the Phase ...
US-based Novavax, Inc. has announced that partner, SK bioscience, has received a Post Approval Change Application approv...
The Asian Development Bank (ADB) has approved a $10 million loan to help the Government of Bhutan purchase safe and effe...
The Health Sciences Authority (HSA) in Singapore, in consultation with its Medicines Advisory Committee, has, gran...
South Korea-based SK bioscience, a global innovative vaccine and biotech company dedicated to promoting human health fro...
US-based Novavax has announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine received expanded manufacturing and marketi...
A team of scientists led by Lee Kong Chian School of Medicine (LKCMedicine) at Nanyang Technological University, Singapo...
South Korea's SK bioscience has extended its partnership with Novavax, a US-based biotechnology company specializing in ...
US-based Moderna has announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional regi...
Brii Biosciences has announced that TSB Therapeutics (Beijing), a joint venture majority-owned by the company, is ...
